WIN-Partners Co., Ltd. (TYO:3183)
1,422.00
-11.00 (-0.77%)
Feb 16, 2026, 3:30 PM JST
WIN-Partners Revenue
WIN-Partners had revenue of 22.54B JPY in the quarter ending December 31, 2025, with 4.90% growth. This brings the company's revenue in the last twelve months to 87.25B, up 5.61% year-over-year. In the fiscal year ending March 31, 2025, WIN-Partners had annual revenue of 81.41B with 5.64% growth.
Revenue (ttm)
87.25B
Revenue Growth
+5.61%
P/S Ratio
0.45
Revenue / Employee
138.49M
Employees
630
Market Cap
39.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 81.41B | 4.35B | 5.64% |
| Mar 31, 2024 | 77.06B | 6.21B | 8.76% |
| Mar 31, 2023 | 70.85B | 4.46B | 6.72% |
| Mar 31, 2022 | 66.39B | 4.27B | 6.87% |
| Mar 31, 2021 | 62.12B | -2.41B | -3.74% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Otsuka Holdings | 2.42T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| YAKUODO HOLDINGS | 161.03B |
| Elan Corporation | 55.45B |
| Daito Pharmaceutical | 51.20B |
| Seikagaku | 35.86B |